Orgenesis Inc (ORGS)

Oct 20, 2025

Why Orgenesis Inc. (45O) stock remains top rated2025 Investor Takeaways & Expert Approved Momentum Ideas - newser.com

Oct 20, 2025

Oct 17, 2025

In-Depth 2025 Common Warts Industry Forecast: Plan Your Strategy for 2034 Success - WhaTech

Oct 17, 2025

Oct 16, 2025

Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts Market: Pushing the Bounda... - WhaTech

Oct 16, 2025

Oct 15, 2025

Will Orgenesis Inc. (45O) stock benefit from infrastructure billJuly 2025 Patterns & Daily Technical Stock Forecast Reports - newser.com

Oct 15, 2025

Oct 13, 2025

Can Orgenesis Inc. (45O) stock withstand sector downturnsJuly 2025 Summary & Free Long-Term Investment Growth Plans - newser.com

Oct 13, 2025

Oct 11, 2025

Orgenesis Presents Technology Update To FDA/CBER Experts - AOL.com

Oct 11, 2025

Oct 09, 2025

Is Orgenesis Inc 45O a good long term investmentFibonacci Retracement Levels & Explosive Trading Portfolio - earlytimes.in

Oct 09, 2025

Oct 03, 2025

Is Orgenesis Inc. (45O) stock a top pick for value investorsTrade Exit Report & Low Drawdown Trading Strategies - newser.com

Oct 03, 2025

Oct 01, 2025

Why Institutions Believe Beeyu Overseas Limited Is Undervalued TodayStock Buyback Updates & High Profit Market Tips - earlytimes.in

Oct 01, 2025

Sep 30, 2025

Orgenesis (NASDAQ:ORGS) and Oragenics (NYSE:OGEN) Critical Contrast - Defense World

Sep 30, 2025

Sep 28, 2025

Orgenesis Faces Multiple Leadership Resignations in August - MSN

Sep 28, 2025

Sep 17, 2025

Orgenesis subsidiary Theracell enters $1 million convertible loan agreement By Investing.com - Investing.com South Africa

Sep 17, 2025

Sep 17, 2025

Orgenesis subsidiary Theracell enters $1 million convertible loan agreement - Investing.com India

Sep 17, 2025

Sep 16, 2025

Orgenesis Subsidiary Secures Convertible Loan Agreement - TipRanks

Sep 16, 2025

Sep 12, 2025

Riku Dining Group Ltd sees U.S. IPO of 2.3 million Class A ordinary shares - MarketScreener

Sep 12, 2025

Sep 10, 2025

LB Pharmaceuticals raises $285 million in US IPO - MarketScreener

Sep 10, 2025

Sep 10, 2025

Genital Warts Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential - Barchart.com

Sep 10, 2025

Sep 09, 2025

Exclusive-Stablecoin issuer Figure Technologies set to upsize IPO as demand for crypto-related stocks soars, source says - MarketScreener

Sep 09, 2025

Sep 07, 2025

Orgenesis’s Sharp Swings Define Its High-Risk Biotech Story - Finimize

Sep 07, 2025